HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways

被引：0
|
作者：
Qing Li
Cong Wang
Yufeng Wang
Liankang Sun
Zhikui Liu
Liang Wang
Tao Song
Yingmin Yao
Qingguang Liu
Kangsheng Tu
机构：
[1] the First Affiliated Hospital of Xi’an Jiaotong University,Department of Hepatobiliary Surgery
来源：
Journal of Experimental & Clinical Cancer Research | / 37卷
关键词：
Hepatocellular carcinoma; Microenvironment; Hepatic stellate cells; COMP; Tumor progression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways
    Li, Qing
    Wang, Cong
    Wang, Yufeng
    Sun, Liankang
    Liu, Zhikui
    Wang, Liang
    Song, Tao
    Yao, Yingmin
    Liu, Qingguang
    Tu, Kangsheng
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37
  • [2] Sortilin 1 regulates hepatocellular carcinoma progression by activating the PI3K/AKT signaling
    Ye, S.
    Wang, B.
    Zhou, Y.
    Sun, Q.
    Yang, X.
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2022, 41
  • [3] Crosstalk between circRNAs and the PI3K/AKT and/or MEK/ERK signaling pathways in digestive tract malignancy progression
    Wu, Chao
    Huang, Xing
    Li, Mao
    Wang, Zihe
    Zhang, Yi
    Tian, Bole
    FUTURE ONCOLOGY, 2022, 18 (40) : 4525 - 4538
  • [4] Caulis Polygoni Multiflori Accelerates Megakaryopoiesis and Thrombopoiesis via Activating PI3K/Akt and MEK/ERK Signaling Pathways
    Yang, Xin
    Wang, Long
    Zeng, Jing
    Wu, Anguo
    Qin, Mi
    Wen, Min
    Zhang, Ting
    Chen, Wang
    Mei, Qibing
    Qin, Dalian
    Yang, Jing
    Jiang, Yu
    Wu, Jianming
    PHARMACEUTICALS, 2022, 15 (10)
  • [5] PODXL promotes malignant progression of hepatocellular carcinoma by activating PI3K/AKT pathway
    Ding, Yifeng
    Wang, Xiaoqing
    Shu, Fei
    Pan, Kehua
    Chen, Xiaohong
    Liu, Qingquan
    JOURNAL OF MOLECULAR HISTOLOGY, 2024, 55 (06) : 1107 - 1120
  • [6] NO donor inhibits proliferation and induces apoptosis by targeting PI3K/AKT/mTOR and MEK/ERK pathways in hepatocellular carcinoma cells
    Liu, Ling
    Chen, Jingjing
    Cao, Mengyao
    Wang, Jiangang
    Wang, Shuying
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (06) : 1303 - 1314
  • [7] RAS/RAF/MEK/ERK and PI3K/PTEN/AKT Signaling in Malignant Melanoma Progression and Therapy
    Yajima, Ichiro
    Kumasaka, Mayuko Y.
    Nguyen Dinh Thang
    Goto, Yuji
    Takeda, Kozue
    Yamanoshita, Osamu
    Iida, Machiko
    Ohgami, Nobutaka
    Tamura, Haruka
    Kawamoto, Yoshiyuki
    Kato, Masashi
    DERMATOLOGY RESEARCH AND PRACTICE, 2012, 2012
  • [8] RUNX2 Plays An Oncogenic Role in Esophageal Carcinoma by Activating the PI3K/AKT and ERK Signaling Pathways
    Lu, Huibin
    Jiang, Tian
    Ren, Kewei
    Li, Zongming
    Ren, Jianzhuang
    Wu, Gang
    Han, Xinwei
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 49 (01) : 217 - 225
  • [9] Targeting of PI3K/AKT and MEK Signaling
    de Bono, J. S.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S84 - S84
  • [10] MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway
    Zhenyu Zhang
    Jinfeng Zhu
    Yansong Huang
    Weibing Li
    Hongqiu Cheng
    Diagnostic Pathology, 13
12345